Living with rheumatoid arthritis means managing a complex condition where tracking progress is vital. Doctors often use specific scores to see if a treatment is working. However, a large study of over 30,000 patients shows that not all scores are equal when it comes to measuring true success.
The study looked at how different scoring methods compared to target-based outcomes, like reaching remission or low disease activity. It found that the ACR20 score significantly overestimated treatment effects compared to these target goals. In other words, a patient might hit the ACR20 mark, but it does not always mean they have reached the deeper goals of the disease.
Other scores, like ACR50 and ACR70, showed much better consistency with target-based outcomes. While the data shows that ACR20 can give a slightly inflated sense of success, the other measures provide a more accurate picture of how well a patient is reaching their goals. Talk to your doctor about which metrics best reflect your personal health goals.
